Clinical Investigator Administrative Actions - Disqualification: Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 1, 2022
January 17, 2023
010473ad-219d-4ac4-a350-3ad80a2d42fb
Related Documents
Evaluation of Sex Differences in Clinical Investigations: Guidance for Industry
Guidance DocumentJanuary 20, 2025Office of the Commissioner
Frequently Asked Questions – Statement of Investigator (Form FDA 1572): Guidance for Sponsors, Clinical Investigators, and IRBs
Guidance DocumentJune 4, 2010Office of the Commissioner
Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors
Guidance DocumentAugust 15, 2023Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox